The Immune Response Generated Against HPV Infection in Men and Its Implications in the Diagnosis of Cancer
Overview
Affiliations
Human papillomavirus (HPV) infection is associated with precancerous lesions and cancer of the genital tract both in women and men. The high incidence of cervical cancer worldwide focused the research on this infection mainly in women and to a lesser extent in men. In this review, we summarized epidemiological, immunological, and diagnostic data associated with HPV and cancer in men. We presented an overview of the main characteristics of HPV and infection in men that are associated with different types of cancer but also associated with male infertility. Men are considered important vectors of HPV transmission to women; therefore, identifying the sexual and social behavioral risk factors associated with HPV infection in men is critical to understand the etiology of the disease. It is also essential to describe how the immune response develops in men during HPV infection or when vaccinated, since this knowledge could help to control the viral transmission to women, decreasing the incidence of cervical cancer, but also could reduce other HPV-associated cancers among men who have sex with men (MSM). Finally, we summarized the methods used over time to detect and genotype HPV genomes, as well as some diagnostic tests that use cellular and viral biomarkers that were identified in HPV-related cancers.
Impact of HIV on HPV-related cancers in men who have sex with men: a review.
Zhang Z, Xing Y, Gong T, Li W, Zhang S, Wei L Front Cell Infect Microbiol. 2025; 14:1428491.
PMID: 39902182 PMC: 11788171. DOI: 10.3389/fcimb.2024.1428491.
Brendle S, Li J, Sun D, Zhu J, Henderson-Redmond A, Morgan D Tumour Virus Res. 2024; 19():200307.
PMID: 39694192 PMC: 11731512. DOI: 10.1016/j.tvr.2024.200307.
Breaking barriers: why including boys and men is key to HPV prevention.
Naidoo D, Govender K, Mantell J BMC Med. 2024; 22(1):525.
PMID: 39516809 PMC: 11549739. DOI: 10.1186/s12916-024-03701-8.
Etemad S, Asghari Baghalan A, Naeimi B, Mehrzad S, Adib Amin S, Soudyab M J Res Health Sci. 2024; 24(4):e00629.
PMID: 39431654 PMC: 11492526. DOI: 10.34172/jrhs.2024.164.
Talapko J, Eric S, Mestrovic T, Stipetic M, Juzbasic M, Katalinic D Cancers (Basel). 2024; 16(17).
PMID: 39272855 PMC: 11394246. DOI: 10.3390/cancers16172997.